Please login to the form below

Not currently logged in
Email:
Password:

Bayer sends warning to doctors over Avelox

German pharma company Bayer has sent letters to doctors in Europe warning of rare incidents of severe liver and skin side effects in patients taking its antibiotic Avelox, following a routine analysis of recent data on side effects.

German pharma company Bayer has sent letters to doctors in Europe warning of rare incidents of severe liver and skin side effects in patients taking its antibiotic Avelox, following a routine analysis of recent data on side effects.

Bayer first added warnings to the Avelox label in ? 2007 but is now reinforcing it with letters.

Avelox is a prescription antibiotic that is used to treat respiratory and other infections.

"The side effects are very rare. But when it happens, it is quite severe to patients. We want doctors to be more aware," said Yvonne Moeller, a spokeswoman at Bayer told Reuters.

Avelox, one of Bayer's best-selling drugs, saw sales of almost Ä400m ($584.4 million) in 2006. In 2007, Avelox sales increased to Ä99m in Q3 2007 from Ä79m in Q3 2006.

15th February 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics